There has been extensive press coverage of proposed U.S. healthcare reforms. Although rapid, radical changes may have been contemplated during the recent election campaign, changes are likely to be staged and incremental. Whatever individual investors think about the proposed reforms and the massive lobbying efforts by the various industry groups, investor focus should be the potential impact of these changes on the revenues, earnings and share prices of healthcare companies.